Follow
Ioannis Katsarolis
Ioannis Katsarolis
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2016
1892016
Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection
C Gogos, A Kotsaki, A Pelekanou, G Giannikopoulos, I Vaki, P Maravitsa, ...
Critical Care 14, 1-12, 2010
1702010
Evaluation of a rapid antigen detection test in the diagnosis of streptococcal pharyngitis in children and its impact on antibiotic prescription
HC Maltezou, V Tsagris, A Antoniadou, L Galani, C Douros, I Katsarolis, ...
Journal of antimicrobial Chemotherapy 62 (6), 1407-1412, 2008
1322008
Compassionate use of remdesivir in children with severe COVID-19
DL Goldman, ML Aldrich, SHF Hagmann, A Bamford, ...
Pediatrics 147 (5), 2021
942021
The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea
K Stamboulidis, D Chatzaki, G Poulakou, S Ioannidou, E Lebessi, ...
The Pediatric infectious disease journal 30 (7), 551-555, 2011
832011
Septic arthritis due to Salmonella enteritidis associated with infliximab use
I Katsarolis, S Tsiodras, P Panagopoulos, E Giannitsioti, G Skarantavos, ...
Scandinavian journal of infectious diseases 37 (4), 304-306, 2005
642005
Idiopathic sclerosing encapsulating peritonitis (or abdominal cocoon)
C Serafimidis, I Katsarolis, S Vernadakis, G Rallis, G Giannopoulos, ...
BMC surgery 6, 1-4, 2006
612006
Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment
I Katsarolis, G Poulakou, S Athanasia, J Kourea-Kremastinou, N Lambri, ...
International journal of antimicrobial agents 35 (1), 62-67, 2010
552010
Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase …
N Lampri, I Galani, G Poulakou, I Katsarolis, G Petrikkos, H Giamarellou, ...
Journal of antimicrobial chemotherapy 67 (10), 2424-2428, 2012
492012
Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology
G Poulakou, I Katsarolis, I Matthaiopoulou, S Tsiodras, S Kanavaki, ...
International journal of antimicrobial agents 30 (1), 87-92, 2007
492007
Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece
I Katsarolis, G Poulakou, A Analitis, I Matthaiopoulou, E Roilides, ...
BMC Infectious Diseases 9, 1-10, 2009
432009
Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in Greece
D Plachouras, A Antoniadou, E Giannitsioti, L Galani, I Katsarolis, ...
BMC public health 14, 1-7, 2014
422014
Reduction of environmental contamination with multidrug-resistant bacteria by copper-alloy coating of surfaces in a highly endemic setting
M Souli, A Antoniadou, I Katsarolis, I Mavrou, E Paramythiotou, ...
infection control & hospital epidemiology 38 (7), 765-771, 2017
262017
Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients
D Hatzaki, G Poulakou, I Katsarolis, N Lambri, M Souli, I Deliolanis, ...
BMC Infectious Diseases 12, 1-10, 2012
182012
Severe dysphagia as the presenting symptom of Wernicke-Korsakoff syndrome in a non-alcoholic man
I Karaiskos, I Katsarolis, L Stefanis
Neurological Sciences 29, 45-46, 2008
162008
Fluoroquinolone treatment of chronic bacterial prostatitis: a prospective cohort study
P Panagopoulos, A Antoniadou, K Kanellakopoulou, S Tsiodras, ...
Journal of Chemotherapy 21 (3), 317-321, 2009
142009
Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone
P Siaperas, A Pefanis, D Iliopoulos, I Katsarolis, A Kyroudi-Voulgari, ...
Antimicrobial agents and chemotherapy 45 (12), 3531-3537, 2001
142001
A switch to Raltegravir improves antiretroviral associated hepatotoxicity in individuals co-infected with HIV and hepatitis C
M Cevik, I Katsarolis, GJ Singh, M Nelson
Journal of Infection 69 (2), 190-193, 2014
132014
Efficacy and safety of an anti-retroviral combination regimen including either efavirenz or lopinavir–ritonavir with a backbone of two nucleoside reverse transcriptase inhibitors
P Panagopoulos, S Tsiodras, A Antoniadou, I Katsarolis, A Papadopoulos, ...
Clinical microbiology and infection 12 (5), 486-489, 2006
132006
Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock‐inferred dates: Evidence that older age, heterosexual risk group …
EG Kostaki, S Limnaios, G Adamis, G Xylomenos, M Chini, N Mangafas, ...
HIV medicine 23 (11), 1143-1152, 2022
122022
The system can't perform the operation now. Try again later.
Articles 1–20